Sign in

CIK 0001894525 · <br>Emerging growth company

Apimeds Pharmaceuticals US, Inc.

Sign in to watch
Ticker
APUS
Exchange
NYSE
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
operating
EIN
851099700
Phone
848-201-5010
Business address
100 MATAWAN RD, SUITE 325, MATAWAN, NJ, 07747
  1. 3 Insider Initial Statement of Ownership
  2. 3 Insider Initial Statement of Ownership
  3. 3 Insider Initial Statement of Ownership
  4. 3 Insider Initial Statement of Ownership
  5. 3 Insider Initial Statement of Ownership
  6. 3 Insider Initial Statement of Ownership
  7. 3 Insider Initial Statement of Ownership
  8. 3 Insider Initial Statement of Ownership
  9. EFFECT Other Notice of Effectiveness
  10. CORRESP Other Correspondence Between Filers and SEC Staff
  11. CORRESP Other Correspondence Between Filers and SEC Staff
  12. UPLOAD Other SEC-generated Letter
  13. POS AM Other Post-effective Amendment for Registration Statement
  14. 10-K/A Report 10-K/A
  15. CORRESP Other Correspondence Between Filers and SEC Staff
  16. CORRESP Other Correspondence Between Filers and SEC Staff
  17. POS AM Other Post-effective Amendment for Registration Statement
  18. UPLOAD Other SEC-generated Letter
  19. UPLOAD Other SEC-generated Letter
  20. POS AM Other Post-effective Amendment for Registration Statement

Page 5 of 7 · 130 filings